|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 68 studies with search of: | Amprenavir OR Agenerase[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir
|
||||
| 2 | Completed |
An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
|
||||
| 3 | Completed |
A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients
|
||||
| 4 | Completed |
A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
|
||||
| 5 | Completed |
A Study of Amprenavir in HIV-Infected Patients
|
||||
| 6 | Unknown † |
Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
|
||||
| 7 | Completed |
A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications
|
||||
| 8 | Completed |
A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir
|
||||
| 9 | Completed |
Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz
|
||||
| 10 | Completed |
A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients
|
||||
| 11 | Completed |
Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers
|
||||
| 12 | Completed |
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
|
||||
| 13 | Completed |
Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.
|
||||
| 14 | Completed |
A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection
|
||||
| 15 | Completed |
A Study of 141W94 in Combination With Other Anti-HIV Drugs
|
||||
| 16 | Completed |
Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
|
||||
| 17 | Completed |
A Comparison of 141W94 and Indinavir in HIV-Infected Patients
|
||||
| 18 | Unknown † |
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
|
||||
| 19 | Unknown † |
Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment
|
||||
| 20 | Completed |
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|